Piotr Lipiński

Has grant

Assistant Professor

Mossakowski Medical Research Institute, Polish Academy of Sciences

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Piotr Lipiński is an Assistant Professor at the Mossakowski Medical Research Institute, Polish Academy of Sciences. His research focuses on the development of peptidomimetic inhibitors and structural analyses of various chemical compounds, particularly in relation to neurokinin receptor biology and wound healing. His recent publications include studies on receptor binding interactions and the synthesis of novel opioid receptor ligands, contributing to advancements in medicinal chemistry.

Recent Grants

Grant: Close

Development of an NK1 receptor homology model based on the data concerning interspecies differences in ligand binding.

Open Date: 2017-07-01

Close Date: 2020-07-01

Grant: Close

Drug Design: Chirality Measures as QSAR descriptors.

Open Date: 2013-03-01

Close Date: 2016-03-01

Articles (13)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (3)

Joanna Matalińska

Mossakowski Medical Research Institute, Polish Academy of Sciences

POLAND

View details

Aleksandra Misicka

Professor

University of Warsaw

POLAND

View details

Przemysław Koźmiński

Institute of Nuclear Chemistry and Technology

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Piotr Lipiński

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

Peptidomimetic inhibitors of the VEGF-A165/NRP-1 complex obtained by modification of the C-terminal arginine

Structural Analysis of 3,5-Bistrifluoromethylhydrocinnamic Acid

The influence of a synthetic growth hormone‐releasing hormone analogue G11 and opioid peptide biphalin on selected fibroblasts parameters relevant to wound healing

NK1 receptor binding of a few low molecular weight 3,5-bistrifluoromethylbenzene derivatives

Gαi-derived peptide binds the µ-opioid receptor

Quantitative chirality in the binding of androgens to their receptor

Synthesis of Fentanyl Triazole Derivatives and their Affinity for Mu-Opioid and Sigma-1 Receptors

Moving out of CF3‐Land: Synthesis, Receptor Affinity, and in silico Studies of NK1 Receptor Ligands Containing a Pentafluorosulfanyl (SF5) Group

Correcting a widespread error: Neuroprotectant N-acetyl-L-tryptophan does not bind to the neurokinin-1 receptor

Fentanyl Structure as a Scaffold for Opioid/Non-Opioid Multitarget Analgesics

In Vitro Biological Evaluation of Aprepitant Based <sup>177</sup>Lu-Radioconjugates

Novel NK1R-Targeted 68Ga-/177Lu-Radioconjugates with Potential Application against Glioblastoma Multiforme: Preliminary Exploration of Structure–Activity Relationships

Docking is not enough: 17-trifluoromethylphenyl trinor PGF2α is only a very weak ligand of neurokinin-1 receptor

Collaborators (3)

Joanna Matalińska

Aleksandra Misicka

Przemysław Koźmiński

Make your next move.